Publicação

RECALCITRANT HERPETIC GENITAL ULCERS TREATED WITH IMIQUIMOD IN ASSOCIATION WITH VALACYCLOVIR

Ver documento

Detalhes bibliográficos
Resumo:The herpes simplex virus is a common cause of genital ulcers. In the immunocompromised, it may have an atypical presentation, with exuberant lesions, frequently resulting in resistance to the mainstream therapeutic options, and a consequent prolonged course.A 25-year-old male with a previous history of common variable immunodeficiency, presented with herpetic extensive genital ulcerations on the inguinoscrotal region. Despite a long period of valacyclovir therapy, the patient remained symptomatic. We decided to add topical 5% imiquimod as an adjunctive therapy, and observed a completed resolution of the ulcerations.Imiquimod, working as a local immunomodulator, stimulates the anti-viral immunologic response. Therefore, it is an alternative in recalcitrant herpetic lesions, especially in the setting of immunosuppression.
Autores principais:Matos, Diogo
Outros Autores:Alves, João; António, Ana Marta; Coelho, Ricardo; Bártolo, Elvira
Assunto:Imiquimod Herpes genitalis Herpes simplex Ulcer Valaciclovir Imiquimod Ulcer Herpes genitais Herpes simples Valaciclovir
Ano:2015
País:Portugal
Tipo de documento:artigo
Instituição associada:Sociedade Portuguesa de Dermatologia e Venereologia
Idioma:português
Origem:Portuguese Journal of Dermatology
Descrição
Resumo:The herpes simplex virus is a common cause of genital ulcers. In the immunocompromised, it may have an atypical presentation, with exuberant lesions, frequently resulting in resistance to the mainstream therapeutic options, and a consequent prolonged course.A 25-year-old male with a previous history of common variable immunodeficiency, presented with herpetic extensive genital ulcerations on the inguinoscrotal region. Despite a long period of valacyclovir therapy, the patient remained symptomatic. We decided to add topical 5% imiquimod as an adjunctive therapy, and observed a completed resolution of the ulcerations.Imiquimod, working as a local immunomodulator, stimulates the anti-viral immunologic response. Therefore, it is an alternative in recalcitrant herpetic lesions, especially in the setting of immunosuppression.